Antitrust enforcers get more firepower to take on pay-for-delay deals
Antitrust enforcers will have another weapon in their arsenal when going after drugmakers for anticompetitive practices because of a measure signed by President Donald Trump earlier this month.
One of the...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login
to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information:
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch